R. MacKay-Dunn

R.
Hector MacKay-Dunn currently works at Copper Fox Metals, Inc., as Independent Director, Farris, Vaughan, Wills & Murphy LLP, as Senior Partner from 2010, Law Society of British Columbia, as Member, Ontario Bar Association, as Member, Alberta Bar Association, as Member, Farris LLP, as Senior Partner from 1982, and British Columbia Bar Association, as Member.
Mr. MacKay-Dunn also formerly worked at Innovate BC, as Chairman from 2002 to 2008, Genome British Columbia, as Chairman from 2002 to 2008, QLT, Inc., as Director, MedGenesis Therapeutix, Inc., as Director, Aspreva Pharmaceuticals Corp., as Secretary & Director from 2004 to 2008, enGene, Inc., as Non-Executive Director from 2004 to 2011, XBiotech, Inc., as Director, Simon Fraser University, as Director-Biotech Advisory Council in 2011, Many Bright Ideas Technologies, Inc., as Secretary & Director in 2010, CANTEST Ltd., as Director, LifeSciences British Columbia, as Director, Tennis-British Columbia, as Director, MOVIT Media Corp., as Independent Director from 2012 to 2014, Leading Edge Endowment Fund, as Director from 2002 to 2013, BC Technology Industry Association, as Director from 2015 to 2019, Tennis Canada, as Director from 2008 to 2018, Aurinia Pharmaceuticals, Inc., as Independent Director from 2019 to 2024, Arbutus Biopharma Corp., as Secretary, the University of British Columbia, as Member-Industry Liaison Office, and The United Way of the Lower Mainland, as President.
Mr. MacKay-Dunn received his undergraduate degree and graduate degree from the University of British Columbia.